Transcription factor PROX1: Its role in development and cancer

Cancer and Metastasis Reviews

Volumn 31, Issue 3-4, 2012, Pages 793-805

  Elsir, Tamador ^a,b   Smits, Anja ^b   Lindström, Mikael S ^a   Nistér, Monica ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cancer; Embryonic development; Glioma; PROX1; Transcription factor

Indexed keywords

CYCLINE; HOMEODOMAIN PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PROX1; UNCLASSIFIED DRUG;

CANCER GROWTH; CANCER STEM CELL; CARCINOGENESIS; CELL MATURATION; CENTRAL NERVOUS SYSTEM TUMOR; DNA METHYLATION; EMBRYO DEVELOPMENT; EYE DEVELOPMENT; GASTROINTESTINAL TUMOR; GENE EXPRESSION; GENE MUTATION; GENE OVEREXPRESSION; GLIOBLASTOMA; GLIOMA; HEART DEVELOPMENT; HEMATOLOGIC MALIGNANCY; HUMAN; LIVER; LYMPHATIC SYSTEM; METASTASIS; NEUROBLASTOMA; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PANCREAS; PERIPHERAL NERVE TUMOR; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN STRUCTURE; REVIEW; STEM CELL; SUMOYLATION;

AMINO ACID SEQUENCE; ANIMALS; DROSOPHILA PROTEINS; EMBRYONIC DEVELOPMENT; EYE; HOMEODOMAIN PROTEINS; HUMANS; LIVER; MOLECULAR SEQUENCE DATA; NEOPLASM METASTASIS; NEOPLASMS; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 84867988893     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/s10555-012-9390-8     Document Type: Review

References (93)

1. Abate-Shen, C. (2002). Deregulated homeobox gene expression in cancer: cause or consequence? Nature Reviews. Cancer, 2(10), 777-785.
2. Oliver, G.; Sosa-Pineda, B.; Geisendorf, S.; Spana, E. P.; Doe, C. Q.; & Gruss, P. (1993). Prox1, a prospero-related homeobox gene expressed during mouse development. Mechanisms of Development, 44(1), 3-16.
3. Zinovieva, R. D.; Duncan, M. K.; Johnson, T. R.; Torres, R.; Polymeropoulos, M. H.; & Tomarev, S. I. (1996). Structure and chromosomal localization of the human homeobox gene Prox1. Genomics, 35(3), 517-522.
4. Banerjee-Basu, S.; Landsman, D.; & Baxevanis, A. D. (1999). Threading analysis of prospero-type homeodomains. In Silico Biology, 1(3), 163-173.
5. Ryter, J. M.; Doe, C. Q.; & Matthews, B. W. (2002). Structure of the DNA binding region of prospero reveals a novel homeo-prospero domain. Structure, 10(11), 1541-1549.
6. Yousef, M. S.; & Matthews, B. W. (2005). Structural basis of prospero-DNA interaction: implications for transcription regulation in developing cells. Structure, 13(4), 601-607.
7. Song, K. H.; Li, T.; & Chiang, J. Y. (2006). A prospero-related homeodomain protein is a novel co-regulator of hepatocyte nuclear factor 4alpha that regulates the cholesterol 7alpha-hydroxylase gene. Journal of Biological Chemistry, 281(15), 10081-10088.
8. Steffensen, K. R.; Holter, E.; Bavner, A.; Nilsson, M.; Pelto-Huikko, M.; Tomarev, S.; et al. (2004). Functional conservation of interactions between a homeodomain cofactor and a mammalian FTZ-F1 homologue. EMBO Reports, 5(6), 613-619.
9. Chen, X.; Patel, T. P.; Simirskii, V. I.; & Duncan, M. K. (2008). PCNA interacts with Prox1 and represses its transcriptional activity. Molecular Vision, 14, 2076-2086.
10. Pan, M. R.; Chang, T. M.; Chang, H. C.; Su, J. L.; Wang, H. W.; & Hung, W. C. (2009). Sumoylation of Prox1 controls its ability to induce VEGFR3 expression and lymphatic phenotypes in endothelial cells. Journal of Cell Science, 122(Pt 18), 3358-3364.
11. Shan, S. F.; Wang, L. F.; Zhai, J. W.; Qin, Y.; Ouyang, H. F.; Kong, Y. Y.; et al. (2008). Modulation of transcriptional corepressor activity of prospero-related homeobox protein (Prox1) by SUMO modification. FEBS Letters, 582(27), 3723-3728.
12. Doe, C. Q.; Chu-LaGraff, Q.; Wright, D. M.; & Scott, M. P. (1991). The prospero gene specifies cell fates in the Drosophila central nervous system. Cell, 65(3), 451-464.
13. Betschinger, J.; & Knoblich, J. A. (2004). Dare to be different: asymmetric cell division in Drosophila, C. elegans and vertebrates. Current Biology, 14(16), R674-R685.
14. Jan, Y. N.; & Jan, L. Y. (1998). Asymmetric cell division. Nature, 392(6678), 775-778.
15. Myster, D. L.; & Duronio, R. J. (2000). To differentiate or not to differentiate? Current Biology, 10(8), R302-R304.
16. Betschinger, J.; Mechtler, K.; & Knoblich, J. A. (2006). Asymmetric segregation of the tumor suppressor brat regulates self-renewal in Drosophila neural stem cells. Cell, 124(6), 1241-1253.
17. Knoblich, J. A. (2008). Mechanisms of asymmetric stem cell division. Cell, 132(4), 583-597.
18. Choksi, S. P.; Southall, T. D.; Bossing, T.; Edoff, K.; de Wit, E.; Fischer, B. E.; et al. (2006). Prospero acts as a binary switch between self-renewal and differentiation in Drosophila neural stem cells. Developmental Cell, 11(6), 775-789.
19. Hirata, J.; Nakagoshi, H.; Nabeshima, Y.; & Matsuzaki, F. (1995). Asymmetric segregation of the homeodomain protein prospero during Drosophila development. Nature, 377(6550), 627-630.
20. Southall, T. D.; & Brand, A. H. (2009). Neural stem cell transcriptional networks highlight genes essential for nervous system development. EMBO Journal, 28(24), 3799-3807.
21. Griffiths, R. L.; & Hidalgo, A. (2004). Prospero maintains the mitotic potential of glial precursors enabling them to respond to neurons. EMBO Journal, 23(12), 2440-2450.
22. Raff, M. C.; Durand, B.; & Gao, F. B. (1998). Cell number control and timing in animal development: the oligodendrocyte cell lineage. International Journal of Developmental Biology, 42(3), 263-267.
23. Stacey, S. M.; Thomas, G. B.; Labbe, A.; & Van Meyel, D. J. (2007). Longitudinal glia in the fly CNS: pushing the envelope on glial diversity and neuron-glial interactions. Neuron Glia Biology, 3(1), 27-33.
24. Hidalgo, A.; & Griffiths, R. (2004). Coupling glial numbers and axonal patterns. Cell Cycle, 3(9), 1118-1120.
25. Freeman, M. R.; Delrow, J.; Kim, J.; Johnson, E.; & Doe, C. Q. (2003). Unwrapping glial biology: gcm target genes regulating glial development, diversification, and function. Neuron, 38(4), 567-580.
26. Freeman, M. R.; & Doe, C. Q. (2001). Asymmetric prospero localization is required to generate mixed neuronal/glial lineages in the Drosophila CNS. Development, 128(20), 4103-4112.
27. Hong, Y. K.; & Detmar, M. (2003). Prox1, master regulator of the lymphatic vasculature phenotype. Cell and Tissue Research, 314(1), 85-92.
28. Weller, M.; & Tautz, D. (2003). Prospero and Snail expression during spider neurogenesis. Development Genes and Evolution, 213(11), 554-566.
29. Wigle, J. T.; Chowdhury, K.; Gruss, P.; & Oliver, G. (1999). Prox1 function is crucial for mouse lens-fibre elongation. Nature Genetics, 21(3), 318-322.
30. Wigle, J. T.; & Oliver, G. (1999). Prox1 function is required for the development of the murine lymphatic system. Cell, 98(6), 769-778.
31. Galeeva, A.; Treuter, E.; Tomarev, S.; & Pelto-Huikko, M. (2007). A prospero-related homeobox gene Prox-1 is expressed during postnatal brain development as well as in the adult rodent brain. Neuroscience, 146(2), 604-616.
32. Lavado, A.; & Oliver, G. (2007). Prox1 expression patterns in the developing and adult murine brain. Developmental Dynamics, 236(2), 518-524.
33. Kaltezioti, V.; Kouroupi, G.; Oikonomaki, M.; Mantouvalou, E.; Stergiopoulos, A.; Charonis, A.; et al. (2010). Prox1 regulates the notch1-mediated inhibition of neurogenesis. PLoS Biology, 8(12), e1000565.
34. Karalay, O.; Doberauer, K.; Vadodaria, K. C.; Knobloch, M.; Berti, L.; Miquelajauregui, A.; et al. (2011). Prospero-related homeobox 1 gene (Prox1) is regulated by canonical Wnt signaling and has a stage-specific role in adult hippocampal neurogenesis. Proceedings of the National Academy of Sciences of the United States of America, 108(14), 5807-5812.
35. Misra, K.; Gui, H.; & Matise, M. P. (2008). Prox1 regulates a transitory state for interneuron neurogenesis in the spinal cord. Developmental Dynamics, 237(2), 393-402.
36. Torii, M.; Matsuzaki, F.; Osumi, N.; Kaibuchi, K.; Nakamura, S.; Casarosa, S.; et al. (1999). Transcription factors Mash-1 and Prox-1 delineate early steps in differentiation of neural stem cells in the developing central nervous system. Development, 126(3), 443-456.
37. Elkouris, M.; Balaskas, N.; Poulou, M.; Politis, P. K.; Panayiotou, E.; Malas, S.; et al. (2011). Sox1 maintains the undifferentiated state of cortical neural progenitor cells via the suppression of Prox1-mediated cell cycle exit and neurogenesis. Stem Cells. doi: 10.1002/stem.554.
38. Deng, W.; Aimone, J. B.; & Gage, F. H. (2010). New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory? Nature Reviews Neuroscience, 11(5), 339-350.
39. Lavado, A.; Lagutin, O. V.; Chow, L. M.; Baker, S. J.; & Oliver, G. (2010). Prox1 is required for granule cell maturation and intermediate progenitor maintenance during brain neurogenesis. PLoS Biology. doi: 10.1371/1000460.
40. Duncan, M. K.; Cui, W.; Oh, D. J.; & Tomarev, S. I. (2002). Prox1 is differentially localized during lens development. Mechanisms of Development, 112(1-2), 195-198.
41. Tomarev, S. I.; Sundin, O.; Banerjee-Basu, S.; Duncan, M. K.; Yang, J. M.; & Piatigorsky, J. (1996). Chicken homeobox gene Prox 1 related to Drosophila prospero is expressed in the developing lens and retina. Developmental Dynamics, 206(4), 354-367.
42. Dyer, M. A.; Livesey, F. J.; Cepko, C. L.; & Oliver, G. (2003). Prox1 function controls progenitor cell proliferation and horizontal cell genesis in the mammalian retina. Nature Genetics, 34(1), 53-58.
43. Burke, Z.; & Oliver, G. (2002). Prox1 is an early specific marker for the developing liver and pancreas in the mammalian foregut endoderm. Mechanisms of Development, 118(1-2), 147-155.
44. Sosa-Pineda, B.; Wigle, J. T.; & Oliver, G. (2000). Hepatocyte migration during liver development requires Prox1. Nature Genetics, 25(3), 254-255.
45. Dufour, C. R.; Levasseur, M. P.; Pham, N. H.; Eichner, L. J.; Wilson, B. J.; Charest-Marcotte, A.; et al. (2011). Genomic convergence among ERRalpha, PROX1, and BMAL1 in the control of metabolic clock outputs. PLoS Genetics, 7(6), e1002143.
46. Charest-Marcotte, A.; Dufour, C. R.; Wilson, B. J.; Tremblay, A. M.; Eichner, L. J.; Arlow, D. H.; et al. (2010). The homeobox protein Prox1 is a negative modulator of ERR{alpha}/PGC-1{alpha} bioenergetic functions. Genes & Development, 24(6), 537-542.
47. Wang, J.; Kilic, G.; Aydin, M.; Burke, Z.; Oliver, G.; & Sosa-Pineda, B. (2005). Prox1 activity controls pancreas morphogenesis and participates in the production of "secondary transition" pancreatic endocrine cells. Developmental Biology, 286(1), 182-194.
48. Wigle, J. T.; Harvey, N.; Detmar, M.; Lagutina, I.; Grosveld, G.; Gunn, M. D.; et al. (2002). An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO Journal, 21(7), 1505-1513.
49. Tammela, T.; & Alitalo, K. (2010). Lymphangiogenesis: molecular mechanisms and future promise. Cell, 140(4), 460-476.
50. Johnson, N. C.; Dillard, M. E.; Baluk, P.; McDonald, D. M.; Harvey, N. L.; Frase, S. L.; et al. (2008). Lymphatic endothelial cell identity is reversible and its maintenance requires Prox1 activity. Genes & Development, 22(23), 3282-3291.
51. Makinen, T.; Norrmen, C.; & Petrova, T. V. (2007). Molecular mechanisms of lymphatic vascular development. Cellular and Molecular Life Sciences, 64(15), 1915-1929.
52. Petrova, T. V.; Makinen, T.; Makela, T. P.; Saarela, J.; Virtanen, I.; Ferrell, R. E.; et al. (2002). Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. EMBO Journal, 21(17), 4593-4599.
53. Rodriguez-Niedenfuhr, M.; Papoutsi, M.; Christ, B.; Nicolaides, K. H.; von Kaisenberg, C. S.; Tomarev, S. I.; et al. (2001). Prox1 is a marker of ectodermal placodes, endodermal compartments, lymphatic endothelium and lymphangioblasts. Anat Embryol (Berl), 204(5), 399-406.
54. Risebro, C. A.; Searles, R. G.; Melville, A. A.; Ehler, E.; Jina, N.; Shah, S.; et al. (2009). Prox1 maintains muscle structure and growth in the developing heart. Development, 136(3), 495-505.
55. Louis, D. N.; Ohgaki, H.; Wiestler, O. D.; Cavenee, W. K.; Burger, P. C.; Jouvet, A.; et al. (2007). The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathologica, 114(2), 97-109.
56. Furnari, F. B.; Fenton, T.; Bachoo, R. M.; Mukasa, A.; Stommel, J. M.; Stegh, A.; et al. (2007). Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes & Development, 21(21), 2683-2710.
57. Elsir, T.; Eriksson, A.; Orrego, A.; Lindstrom, M. S.; & Nister, M. (2010). Expression of PROX1 Is a common feature of high-grade malignant astrocytic gliomas. Journal of Neuropathology and Experimental Neurology, 69(2), 129-138.
58. Elsir, T.; Qu, M.; Berntsson, S. G.; Orrego, A.; Olofsson, T.; Lindstrom, M. S.; et al. (2011). PROX1 is a predictor of survival for gliomas WHO grade II. British Journal of Cancer, 104(11), 1747-1754.
59. Holmberg, J.; He, X.; Peredo, I.; Orrego, A.; Hesselager, G.; Ericsson, C.; et al. (2011). Activation of neural and pluripotent stem cell signatures correlates with increased malignancy in human glioma. PLoS One. doi: 10.1371/journal.pone.0018454.
60. Grau, S. J.; Trillsch, F.; von Luttichau, I.; Nelson, P. J.; Herms, J.; Tonn, J. C.; et al. (2008). Lymphatic phenotype of tumour vessels in malignant gliomas. Neuropathology and Applied Neurobiology, 34(6), 675-679.
61. Jenny, B.; Harrison, J. A.; Baetens, D.; Tille, J. C.; Burkhardt, K.; Mottaz, H.; et al. (2006). Expression and localization of VEGF-C and VEGFR-3 in glioblastomas and haemangioblastomas. The Journal of Pathology, 209(1), 34-43.
62. Mueller, S.; & Matthay, K. K. (2009). Neuroblastoma: biology and staging. Current Oncology Reports, 11(6), 431-438.
63. Becker, J.; Wang, B.; Pavlakovic, H.; Buttler, K.; & Wilting, J. (2010). Homeobox transcription factor Prox1 in sympathetic ganglia of vertebrate embryos: correlation with human stage 4 s neuroblastoma. Pediatric Research, 68(2), 112-117.
64. Kinzler, K. W.; & Vogelstein, B. (1996). Lessons from hereditary colorectal cancer. Cell, 87(2), 159-170.
65. Petrova, T. V.; Nykanen, A.; Norrmen, C.; Ivanov, K. I.; Andersson, L. C.; Haglund, C.; et al. (2008). Transcription factor PROX1 induces colon cancer progression by promoting the transition from benign to highly dysplastic phenotype. Cancer Cell, 13(5), 407-419.
66. Edvardsson, K.; Strom, A.; Jonsson, P.; Gustafsson, J. A.; & Williams, C. (2011). Estrogen receptor beta induces antiinflammatory and antitumorigenic networks in colon cancer cells. Molecular Endocrinology, 25(6), 969-979.
67. Skog, M.; Bono, P.; Lundin, M.; Lundin, J.; Louhimo, J.; Linder, N.; et al. (2011). Expression and prognostic value of transcription factor PROX1 in colorectal cancer. British Journal of Cancer, 2011(4), 297.
68. Shimoda, M.; Takahashi, M.; Yoshimoto, T.; Kono, T.; Ikai, I.; & Kubo, H. (2006). A homeobox protein, prox1, is involved in the differentiation, proliferation, and prognosis in hepatocellular carcinoma. Clinical Cancer Research, 12(20 Pt 1), 6005-6011.
69. Akagami, M.; Kawada, K.; Kubo, H.; Kawada, M.; Takahashi, M.; Kaganoi, J.; et al. (2011). Transcriptional factor Prox1 plays an essential role in the antiproliferative action of interferon-gamma in esophageal cancer cells. Annals of Surgical Oncology, 18(13), 3868-3877.
70. Kaganoi, J.; Watanabe, G.; Okabe, M.; Nagatani, S.; Kawabe, A.; Shimada, Y.; et al. (2007). STAT1 activation-induced apoptosis of esophageal squamous cell carcinoma cells in vivo. Annals of Surgical Oncology, 14(4), 1405-1415.
71. Schneider, M.; Buchler, P.; Giese, N.; Giese, T.; Wilting, J.; Buchler, M. W.; et al. (2006). Role of lymphangiogenesis and lymphangiogenic factors during pancreatic cancer progression and lymphatic spread. International Journal of Oncology, 28(4), 883-890.
72. Laerm, A.; Helmbold, P.; Goldberg, M.; Dammann, R.; Holzhausen, H. J.; & Ballhausen, W. G. (2007). Prospero-related homeobox 1 (PROX1) is frequently inactivated by genomic deletions and epigenetic silencing in carcinomas of the bilary system. Journal of Hepatology, 46(1), 89-97.
73. Nagai, H.; Li, Y.; Hatano, S.; Toshihito, O.; Yuge, M.; Ito, E.; et al. (2003). Mutations and aberrant DNA methylation of the PROX1 gene in hematologic malignancies. Genes, Chromosomes & Cancer, 38(1), 13-21.
74. Versmold, B.; Felsberg, J.; Mikeska, T.; Ehrentraut, D.; Kohler, J.; Hampl, J. A.; et al. (2007). Epigenetic silencing of the candidate tumor suppressor gene PROX1 in sporadic breast cancer. International Journal of Cancer, 121(3), 547-554.
75. Uldrick, T. S.; & Whitby, D. (2011). Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma. Cancer Letters, 305(2), 150-162.
76. Jussila, L.; Valtola, R.; Partanen, T. A.; Salven, P.; Heikkila, P.; Matikainen, M. T.; et al. (1998). Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. Cancer Research, 58(8), 1599-1604.
77. Hong, Y. K.; Foreman, K.; Shin, J. W.; Hirakawa, S.; Curry, C. L.; Sage, D. R.; et al. (2004). Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus. Nature Genetics, 36(7), 683-685.
78. Yoo, J.; Kang, J.; Lee, H. N.; Aguilar, B.; Kafka, D.; Lee, S.; et al. (2010). Kaposin-B enhances the PROX1 mRNA stability during lymphatic reprogramming of vascular endothelial cells by Kaposi's sarcoma herpes virus. PLoS Pathogens, 6(8), e1001046.
79. Elyada, E.; Pribluda, A.; Goldstein, R. E.; Morgenstern, Y.; Brachya, G.; Cojocaru, G.; et al. (2011). CKIalpha ablation highlights a critical role for p53 in invasiveness control. Nature, 470(7334), 409-413.
80. Dadras, S. S.; Skrzypek, A.; Nguyen, L.; Shin, J. W.; Schulz, M. M.; Arbiser, J.; et al. (2008). Prox-1 promotes invasion of kaposiform hemangioendotheliomas. The Journal of Investigative Dermatology, 128(12), 2798-2806.
81. Cao, Y. (2005). Opinion: emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis. Nature Reviews. Cancer, 5(9), 735-743.
82. Duong, T.; Koopman, P.; & Francois, M. (2012). Tumor lymphangiogenesis as a potential therapeutic target. J Oncol. doi: 10.1155/2012/204946.
83. Hope, K. J.; Cellot, S.; Ting, S. B.; MacRae, T.; Mayotte, N.; Iscove, N. N.; et al. (2010). An RNAi screen identifies Msi2 and Prox1 as having opposite roles in the regulation of hematopoietic stem cell activity. Cell Stem Cell, 7(1), 101-113.
84. Monzani, E.; Facchetti, F.; Galmozzi, E.; Corsini, E.; Benetti, A.; Cavazzin, C.; et al. (2007). Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. European Journal of Cancer, 43(5), 935-946.
85. Balla, M. M.; Vemuganti, G. K.; Kannabiran, C.; Honavar, S. G.; & Murthy, R. (2009). Phenotypic characterization of retinoblastoma for the presence of putative cancer stem-like cell markers by flow cytometry. Investigative Ophthalmology & Visual Science, 50(4), 1506-1514.
86. Steiner, B.; Zurborg, S.; Horster, H.; Fabel, K.; & Kempermann, G. (2008). Differential 24 h responsiveness of Prox1-expressing precursor cells in adult hippocampal neurogenesis to physical activity, environmental enrichment, and kainic acid-induced seizures. Neuroscience, 154(2), 521-529.
87. Zheng, H.; Ying, H.; Yan, H.; Kimmelman, A. C.; Hiller, D. J.; Chen, A. J.; et al. (2008). Pten and p53 converge on c-Myc to control differentiation, self-renewal, and transformation of normal and neoplastic stem cells in glioblastoma. Cold Spring Harbor Symposia on Quantitative Biology, 73, 427-437.
88. Srinivasan, R. S.; Geng, X.; Yang, Y.; Wang, Y.; Mukatira, S.; Studer, M.; et al. (2010). The nuclear hormone receptor Coup-TFII is required for the initiation and early maintenance of Prox1 expression in lymphatic endothelial cells. Genes & Development, 24(7), 696-707.
89. Yoshimatsu, Y.; Yamazaki, T.; Mihira, H.; Itoh, T.; Suehiro, J.; Yuki, K.; et al. (2011). Ets family members induce lymphangiogenesis through physical and functional interaction with Prox1. Journal of Cell Science, 124(Pt 16), 2753-2762.
90. Azuma, K.; Urano, T.; Watabe, T.; Ouchi, Y.; & Inoue, S. (2011). PROX1 suppresses vitamin K-induced transcriptional activity of steroid and xenobiotic receptor. Genes to Cells, 16(11), 1063-1070.
91. Takahashi, M.; Yoshimoto, T.; Shimoda, M.; Kono, T.; Koizumi, M.; Yazumi, S.; et al. (2006). Loss of function of the candidate tumor suppressor prox1 by RNA mutation in human cancer cells. Neoplasia, 8(12), 1003-1010.
92. Dudas, J.; Mansuroglu, T.; Moriconi, F.; Haller, F.; Wilting, J.; Lorf, T.; et al. (2008). Altered regulation of Prox1-gene-expression in liver tumors. BMC Cancer, 8(92), 92.
93. Yoshimoto, T.; Takahashi, M.; Nagayama, S.; Watanabe, G.; Shimada, Y.; Sakasi, Y.; et al. (2007). RNA mutations of prox1 detected in human esophageal cancer cells by the shifted termination assay. Biochemical and Biophysical Research Communications, 359(2), 258-262.